Parkinson's disease: reduce risk by ibuprofen

According to a study conducted by the National Institute of Neurological Disorders and Stroke and presented at the 62nd Annual Meeting of the American Academy of Neurology to be held from 10 to 17 April in Toronto, regular consumers of ibuprofen had by 40% less chance of developing Parkinson's disease than others.

The study also reveals that people who consume large quantities of ibuprofen were less likely to develop Parkinson's than those who ate little.

The study was conducted on 136,474 people who were not suffering from Parkinson's disease. Researchers have drawn up lists for each participant indicating whether or not taking anti-inflammatories (aspirin, ibuprofen or paracetamol).

After six years, 293 participants developed Parkinson's disease.

"Ibuprofen is the only anti-inflammatory that had a positive impact on Parkinson's disease. Other anti-inflammatory drugs had no effect on the disease. Further research is needed to understand why and how ibuprofen may have an effect on this disease, " explains Dr. Xiang Gao.

• Know about Various Ear Diseases
• COPD or chronic obstructive pulmonary disease
• Myopathy: The promise of pharmacogenetics
• A supergonococci resistant to all common antibiotics
• E.coli: Undercooked meat is the main source
• Malaria: A promising discovery
• Alzheimer's: The real signals for a correct diagnosis
• Chariots of death